On construction of single‐arm two‐stage designs with consideration of both response and toxicity

DOI10.1002/BIMJ.201800320zbMath1429.62637OpenAlexW2971983261WikidataQ92530474 ScholiaQ92530474MaRDI QIDQ5213411

Huan Yin, Weizhen Wang, Zhong-Zhan Zhang

Publication date: 3 February 2020

Published in: Biometrical Journal (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1002/bimj.201800320

zbMATH Keywords

conditional distributionphase II clinical trialsmultinomial distributionsminimum powermaximum Type I error rate

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (2)

On optimal subset designs for phase II clinical trials with both total response and disease control ⋮ Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials

This page was built for publication: On construction of single‐arm two‐stage designs with consideration of both response and toxicity